Yoji Kuze

Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents:  Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety

Masaki Seto, Katsuji Aikawa, Naoki Miyamoto et al. · Journal of Medicinal Chemistry · 2006 · 89 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Effect of Multiple Dosing of Ketoconazole on Pharmacokinetics of Midazolam, a Cytochrome P-450 3A Substrate in Beagle Dogs

Masanori Kuroha, Akinori Azumano, Yoji Kuze et al. · Drug Metabolism and Disposition · 2002 · 64 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

Toshihiko Doi, Hiroya Takiuchi, Atsushi Ohtsu et al. · British Journal of Cancer · 2012 · 42 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes

Masanori Kuroha, Yoji Kuze, Minoru Shimoda et al. · American Journal of Veterinary Research · 2002 · 38 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Development, validation and application of the liquid chromatography tandem mass spectrometry method for simultaneous quantification of azilsartan medoxomil (TAK-491), azilsartan (TAK-536), and its 2 metabolites in human plasma

Yoji Kuze, Akifumi Kogame, Fumihiro Jinno et al. · Journal of Chromatography B · 2015 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +16